176 related articles for article (PubMed ID: 15542591)
1. Residues 10-18 within the C5a receptor N terminus compose a binding domain for chemotaxis inhibitory protein of Staphylococcus aureus.
Postma B; Kleibeuker W; Poppelier MJ; Boonstra M; Van Kessel KP; Van Strijp JA; de Haas CJ
J Biol Chem; 2005 Jan; 280(3):2020-7. PubMed ID: 15542591
[TBL] [Abstract][Full Text] [Related]
2. Structure of the tyrosine-sulfated C5a receptor N terminus in complex with chemotaxis inhibitory protein of Staphylococcus aureus.
Ippel JH; de Haas CJ; Bunschoten A; van Strijp JA; Kruijtzer JA; Liskamp RM; Kemmink J
J Biol Chem; 2009 May; 284(18):12363-72. PubMed ID: 19251703
[TBL] [Abstract][Full Text] [Related]
3. Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor.
Postma B; Poppelier MJ; van Galen JC; Prossnitz ER; van Strijp JA; de Haas CJ; van Kessel KP
J Immunol; 2004 Jun; 172(11):6994-7001. PubMed ID: 15153520
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine sulfation in N-terminal domain of human C5a receptor is necessary for binding of chemotaxis inhibitory protein of Staphylococcus aureus.
Liu ZJ; Yang YJ; Jiang L; Xu YC; Wang AX; Du GH; Gao JM
Acta Pharmacol Sin; 2011 Aug; 32(8):1038-44. PubMed ID: 21706042
[TBL] [Abstract][Full Text] [Related]
5. N-terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor.
Haas PJ; de Haas CJ; Kleibeuker W; Poppelier MJ; van Kessel KP; Kruijtzer JA; Liskamp RM; van Strijp JA
J Immunol; 2004 Nov; 173(9):5704-11. PubMed ID: 15494522
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of receptor binding by the chemotaxis inhibitory protein of Staphylococcus aureus and the effects of the host immune response.
Wright AJ; Higginbottom A; Philippe D; Upadhyay A; Bagby S; Read RC; Monk PN; Partridge LJ
Mol Immunol; 2007 Apr; 44(10):2507-17. PubMed ID: 17258808
[TBL] [Abstract][Full Text] [Related]
7. Structural models for the complex of chemotaxis inhibitory protein of Staphylococcus aureus with the C5a receptor.
Nikiforovich GV; Baranski TJ
Biochem Biophys Res Commun; 2009 Dec; 390(3):481-4. PubMed ID: 19799858
[TBL] [Abstract][Full Text] [Related]
8. The structure of the C5a receptor-blocking domain of chemotaxis inhibitory protein of Staphylococcus aureus is related to a group of immune evasive molecules.
Haas PJ; de Haas CJ; Poppelier MJ; van Kessel KP; van Strijp JA; Dijkstra K; Scheek RM; Fan H; Kruijtzer JA; Liskamp RM; Kemmink J
J Mol Biol; 2005 Nov; 353(4):859-72. PubMed ID: 16213522
[TBL] [Abstract][Full Text] [Related]
9. The NH2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding.
Mery L; Boulay F
J Biol Chem; 1994 Feb; 269(5):3457-63. PubMed ID: 8106386
[TBL] [Abstract][Full Text] [Related]
10. CHIPS binds to the phosphorylated N-terminus of the C5a-receptor.
Bunschoten A; Feitsma LJ; Kruijtzer JA; de Haas CJ; Liskamp RM; Kemmink J
Bioorg Med Chem Lett; 2010 Jun; 20(11):3338-40. PubMed ID: 20457523
[TBL] [Abstract][Full Text] [Related]
11. Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor.
Nikiforovich GV; Marshall GR; Baranski TJ
Biochemistry; 2008 Mar; 47(10):3117-30. PubMed ID: 18275159
[TBL] [Abstract][Full Text] [Related]
12. Identification of conformational epitopes for human IgG on Chemotaxis inhibitory protein of Staphylococcus aureus.
Gustafsson E; Haas PJ; Walse B; Hijnen M; Furebring C; Ohlin M; van Strijp JA; van Kessel KP
BMC Immunol; 2009 Mar; 10():13. PubMed ID: 19284584
[TBL] [Abstract][Full Text] [Related]
13. A peptide mimic of the chemotaxis inhibitory protein of Staphylococcus aureus: towards the development of novel anti-inflammatory compounds.
Bunschoten A; Ippel JH; Kruijtzer JA; Feitsma L; de Haas CJ; Liskamp RM; Kemmink J
Amino Acids; 2011 Feb; 40(2):731-40. PubMed ID: 20683629
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of the gerbil C5a receptor and identification of a transmembrane domain V amino acid that is crucial for small molecule antagonist interaction.
Waters SM; Brodbeck RM; Steflik J; Yu J; Baltazar C; Peck AE; Severance D; Zhang LY; Currie K; Chenard BL; Hutchison AJ; Maynard G; Krause JE
J Biol Chem; 2005 Dec; 280(49):40617-23. PubMed ID: 16230349
[TBL] [Abstract][Full Text] [Related]
15. A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR.
Prat C; Haas PJ; Bestebroer J; de Haas CJ; van Strijp JA; van Kessel KP
J Immunol; 2009 Nov; 183(10):6569-78. PubMed ID: 19846866
[TBL] [Abstract][Full Text] [Related]
16. The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding.
J Biol Chem; ; . PubMed ID: 17158873
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
